Schrodinger, Inc. (NASDAQ:SDGR) Receives Average Rating of "Hold" from Analysts

Key Points

• Analyst sentiment is mixed: Seven firms rate Schrodinger an average “Hold,” with three buys, three holds and one sell. The average 12-month price target is $20.50, below the reported $29.02 opening price.
• Recent quarterly results exceeded expectations: Schrodinger reported adjusted EPS of $0.08 versus the consensus estimate of a $0.41 loss, while revenue reached $58.89 million, up 7.5% year over year.
• The stock remains volatile and unprofitable: Shares were reported down 4.0%, with a beta of 1.69, a negative price-to-earnings ratio of -39.22 and analysts forecasting a full-year loss of $1.50 per share.

Shares of Schrodinger, Inc. (NASDAQ:SDGR - Get Free Report) have received an average recommendation of "Hold" from the seven research firms that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target price among brokers that have covered the stock in the last year is $20.50.

Several equities research analysts have recently commented on the stock. Weiss Ratings upgraded shares of Schrodinger from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Thursday, August 27th. Wall Street Zen upgraded Schrodinger from a "strong sell" rating to a "hold" rating in a research note on Saturday, August 8th. Finally, UBS Group started coverage on Schrodinger in a research note on Friday, August 14th. They set a "neutral" rating and a $19.00 price target on the stock.

Schrodinger Trading Down 4.0%

Shares of SDGR stock opened at $29.02 on Friday. Schrodinger has a 12-month low of $10.94 and a 12-month high of $30.41. The business's fifty day simple moving average is $18.51 and its 200-day simple moving average is $15.18. The company has a market cap of $2.14 billion, a PE ratio of -39.22 and a beta of 1.69.

Schrodinger (NASDAQ:SDGR - Get Free Report) last announced its earnings results on Wednesday, August 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.41) by $0.49. Schrodinger had a negative return on equity of 16.37% and a negative net margin of 20.98%.The company had revenue of $58.89 million for the quarter, compared to analyst estimates of $47.19 million. During the same period in the prior year, the company posted ($0.65) EPS. The firm's quarterly revenue was up 7.5% compared to the same quarter last year. On average, equities analysts forecast that Schrodinger will post -1.5 earnings per share for the current year.

Hedge Funds Weigh In On Schrodinger

Several hedge funds and other institutional investors have recently bought and sold shares of SDGR. Handelsbanken Fonder AB lifted its stake in Schrodinger by 6.3% during the 4th quarter. Handelsbanken Fonder AB now owns 15,200 shares of the company's stock valued at $272,000 after acquiring an additional 900 shares during the period. Kestra Advisory Services LLC raised its holdings in shares of Schrodinger by 2.0% during the first quarter. Kestra Advisory Services LLC now owns 51,429 shares of the company's stock worth $584,000 after purchasing an additional 1,002 shares during the last quarter. EverSource Wealth Advisors LLC raised its holdings in shares of Schrodinger by 722.8% during the fourth quarter. EverSource Wealth Advisors LLC now owns 1,374 shares of the company's stock worth $25,000 after purchasing an additional 1,207 shares during the last quarter. Hantz Financial Services Inc. lifted its position in Schrodinger by 5,025.8% during the fourth quarter. Hantz Financial Services Inc. now owns 1,589 shares of the company's stock valued at $28,000 after purchasing an additional 1,558 shares during the period. Finally, Stephens Inc. AR lifted its position in Schrodinger by 15.8% during the fourth quarter. Stephens Inc. AR now owns 12,618 shares of the company's stock valued at $226,000 after purchasing an additional 1,724 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Schrodinger Company Profile

Schrödinger, Inc develops computational software designed to accelerate drug discovery and materials science research. Its platform uses physics-based modeling, machine learning and related computational methods to help scientists analyze molecular structures, predict interactions and identify potential compounds for further development.

The company's software products support a range of research activities, including molecular modeling, virtual screening, structure-based drug design, free-energy calculations and collaborative data management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.